Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
173.98B
Market cap173.98B
Price-Earnings ratio
42.91
Price-Earnings ratio42.91
Dividend yield
5.73%
Dividend yield5.73%
Average volume
34.25M
Average volume34.25M
High today
$30.90
High today$30.90
Low today
$30.04
Low today$30.04
Open price
$30.74
Open price$30.74
Volume
21.49M
Volume21.49M
52 Week high
$31.06
52 Week high$31.06
52 Week low
$23.62
52 Week low$23.62

Stock Snapshot

As of today, Pfizer(PFE) shares are valued at $30.53. The company's market cap stands at 173.98B, with a P/E ratio of 42.91 and a dividend yield of 5.73%.

On 2026-11-04, Pfizer(PFE) stock moved within a range of $30.04 to $30.90. With shares now at $30.53, the stock is trading +1.6% above its intraday low and -1.2% below the session's peak.

Trading activity shows a volume of 21.49M, compared to an average daily volume of 34.25M.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $31.06 and a low of $23.62.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $31.06 and a low of $23.62.

PFE News

The Motley Fool 3h
Pfizer: 3 Key Takeaways for Long-Term Investors

On its third-quarter 2026 earnings call, held on Nov. 3, 2026, Pfizer (PFE -2.19%) raised its full-year revenue outlook to a range of $62 billion to $64 billion...

Pfizer: 3 Key Takeaways for Long-Term Investors
Investing.com 4h
United Therapeutics buys out Pfizer royalty for $525 million - Investing.com

...

United Therapeutics buys out Pfizer royalty for $525 million - Investing.com
Benzinga 6h
Amazon, Pfizer, Eaton And A Financial Stock On CNBC’s ‘Final Trades’

On CNBC’s “Halftime Report Final Trades,” Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, picked Amazon.com, Inc. (NASDAQ:AMZN). On the earning...

Amazon, Pfizer, Eaton And A Financial Stock On CNBC’s ‘Final Trades’

Analyst ratings

62%

of 29 ratings
Buy
27.6%
Hold
62.1%
Sell
10.3%

More PFE News

Simply Wall St 10h
Pfizer Appoints Cecile Guegan As Permanent Chief Financial Officer

Pfizer (NYSE:PFE) has appointed Cecile Guegan as its permanent Chief Financial Officer after she served in the role on an interim basis. Her promotion follows...

Pfizer Appoints Cecile Guegan As Permanent Chief Financial Officer
TipRanks 17h
Pfizer Earnings Call Signals Growth Beyond COVID

Pfizer Inc ((PFE)) has held its Q3 earnings call. Read on for the main highlights of the call. Pfizer’s earnings call carried a strongly positive tone, with ma...

Benzinga 24h
Nasdaq Surges 1%; Pfizer Posts Upbeat Q3 Earnings

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 1% on Tuesday. The Dow traded down 0.46% to 51,744.97 while the NASDAQ...

Nasdaq Surges 1%; Pfizer Posts Upbeat Q3 Earnings
TipRanks 1d
Pfizer’s New Cancer Study Keeps Investors Watching the Pipeline

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer’s New Cancer Study Keeps Investors Watching the Pipeline Study Overview: Pfizer i...

Benzinga 1d
Non-COVID Portfolio Steps Up: Pfizer Outpaces Consensus and Hikes Guidance

Pfizer Inc. (NYSE:PFE) on Tuesday reported third-quarter sales of $16.58 billion, beating the consensus of $15.87 billion. The company said revenues came in ah...

Non-COVID Portfolio Steps Up: Pfizer Outpaces Consensus and Hikes Guidance
Zacks 1d
Pfizer Reports Q3 Earnings: What Key Metrics Have to Say

Pfizer (PFE Quick QuotePFE - Free Report) reported $16.58 billion in revenue for the quarter ended September 2026, representing a year-over-year decline o...

Pfizer Reports Q3 Earnings: What Key Metrics Have to Say
The Motley Fool 1d
Pfizer's Eliquis Price Gains Cover COVID Drop: Rapid Earnings Reaction

Pfizer (PFE +0.49%) reported flat third-quarter revenue of $16.6 billion and raised its full-year outlook. Shares slipped about 0.2% in premarket trading. Eliqu...

Pfizer's Eliquis Price Gains Cover COVID Drop: Rapid Earnings Reaction

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.